UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY

Back to CRNX Full portfolio

Position in CRNX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$8,358,244

-$2,154,697 QoQ

Shares Held

230,128

+1.9% QoQ

Ownership

0.218%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

24 quarters on record

Voting authority Sole 51.91415212403532.ToString("F0")% Shared 0.ToString("F0")% None 48.08584787596468.ToString("F0")%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,605,812 across 211 Biotechnology names. CRNX ranks #46 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,057,396	$1,365,249,602
2	REGN	Regeneron Pharmaceuticals, Inc.	723,621	$559,098,523
3	ALNY	Alnylam Pharmaceuticals, Inc.	677,519	$224,170,706
4	INSM	INSMED Inc	1,215,025	$198,680,883
5	RPRX	Royalty Pharma plc	3,095,766	$148,503,890
6	INCY	Incyte Corp	1,540,913	$145,030,725
7	IONS	Ionis Pharmaceuticals Inc	1,475,632	$110,805,201
8	DNLI	Denali Therapeutics Inc.	4,432,314	$85,100,425

All Filings in CRNX

Export CSV

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,358,244	230,128	+1.9%	Shares	Defined	2026-05-13
2025-12-31	$10,512,941	225,842	+3.7%	Shares	Defined	2026-02-13
2025-09-30	$9,066,784	217,690	-35.0%	Shares	Sole	2025-11-14
2025-06-30	$9,628,729	334,796	-3.7%	Shares	Defined	2025-08-14
2025-03-31	$11,657,862	347,581	+6.9%	Shares	Defined	2025-05-19
2024-12-31	$16,631,356	325,276	+19.7%	Shares	Defined	2025-02-14
2024-09-30	$13,886,267	271,747	+4.1%	Shares	Defined	2024-11-14
2024-06-30	$11,689,290	260,980	+23.2%	Shares	Defined	2024-08-14
2024-03-31	$9,915,291	211,820	+235.3%	Shares	Defined	2024-05-15
2023-12-31	$2,247,764	63,175	+0.6%	Shares	Sole	2024-02-14
2023-09-30	$1,868,443	62,826	+357.1%	Shares	Sole	2023-11-13
2023-06-30	$247,683	13,745	0.0%	Shares	Defined	2023-08-11
2023-03-31	$220,743	13,745	-47.3%	Shares	Defined	2023-05-15
2022-12-31	$477,006	26,066	0.0%	Shares	Defined	2023-02-14
2022-09-30	$511,935	26,066	+89.6%	Shares	Defined	2022-11-14
2022-06-30	$256,343	13,745	-8.5%	Shares	Defined	2022-08-12
2022-03-31	$329,709	15,021	-34.6%	Shares	Defined	2022-05-16
2021-12-31	$652,633	22,972	+42.3%	Shares	Defined	2022-02-14
2021-09-30	$339,746	16,140	0.0%	Shares	Defined	2021-11-15
2021-06-30	$304,238	16,140	+11.3%	Shares	Defined	2021-08-16
2021-03-31	$221,605	14,503	0.0%	Shares	Defined	2021-05-14
2020-12-31	$204,637	14,503	+38.1%	Shares	Defined	2021-03-01
2020-09-30	$164,582	10,503	-68.4%	Shares	Defined	2020-11-13
2020-06-30	$582,610	33,254	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.